Logistics

Robust supply chain management is particularly critical for autologous cell therapy products due to their highly individualized and time-sensitive nature. Unlike traditional therapies, autologous cell therapies rely on patient-specific materials, requiring precise coordination from collection to processing, manufacturing, and reinfusion. The viability and integrity of these cells depend on stringent environmental controls, temperature monitoring, and seamless logistical operations. Any delays, errors, or mishandling in the supply chain can compromise product quality, efficacy, or safety, directly impacting patient outcomes. Additionally, the regulatory requirements for traceability and chain-of-identity are stringent, necessitating meticulous documentation and quality assurance at every stage. A well-designed supply chain ensures not only compliance with these regulations but also enhances operational efficiency, reduces risks, and ultimately supports the timely delivery of these life-saving therapies to patients.

Here at FamiCord we currently store >1,000,000 samples across our network with routine transport of >100,000 samples between sites and hospitals per year. Our logistics team is responsible for implementing a suitable logistics system for cold chain management and temperature control systems, real-time monitoring, validated packaging of the drug products, regulatory compliance and risk management strategies as part of the shipment process.